Ascendis Pharma's total assets for Q2 2025 were €1.09B, an increase of 2.49% from the previous quarter. ASND total liabilities were €1.28B for the fiscal quarter, a 1.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.